Skip to main navigation

Main Nav

About Us
Scientific Platform
Our Pipeline
Career Opportunities
Investors & Media

Press Releases

IR Nav

Overview
Press Releases
Events
Presentations
Annual Reports
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
FAQs
Email Alerts
Investor Contact

Shareholder Tools

Press Releases

Year

Gritstone Oncology to Present at Two Upcoming Investor Conferences in June

June 4, 2020

Gritstone Oncology Reports First Quarter Financial Results and Recent Highlights

May 7, 2020

Gritstone Oncology Announces the Appointment of Dr. Elaine V. Jones as Chair of the Board of Directors

May 1, 2020

Gritstone Oncology Announces the Appointment of Veteran Legal Executive Rahsaan Thompson as General Counsel

April 6, 2020

Gritstone Oncology Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights

March 11, 2020

Gritstone Oncology to Present at Two Investor Conferences in March

February 25, 2020

Gritstone Oncology to Present at the 38th Annual J.P. Morgan Healthcare Conference

January 8, 2020

Gritstone Oncology Reports Promising Early Immunogenicity Activity and Safety Data from its Phase 1 Studies Evaluating its Neoantigen-based Immunotherapies, GRANITE and SLATE

December 12, 2019

Gritstone Oncology to Webcast a Review of the Clinical Immunogenicity Data from its Neoantigen-based Immunotherapies that will be Presented at the ESMO Immuno-Oncology Congress

December 9, 2019

Gritstone Oncology to Present at the Piper Jaffray Annual Healthcare Conference

November 26, 2019

Pagination

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Next page
Last page

© 2021 Gritstone Bio |

Footer Links

Privacy Policy
Terms of Use
Contact

socials

Top